BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Abdel-Razik A, Mousa N, Elhelaly R, Elzehery R, Hasan AS, Abdelsalam M, Seif AS, Tawfik AM, El-Wakeel N, Eldars W. Helicobacter pylori as an Initiating Factor of Complications in Patients With Cirrhosis: A Single-Center Observational Study. Front Med (Lausanne) 2020;7:96. [PMID: 32266280 DOI: 10.3389/fmed.2020.00096] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 El Sheref SEDM, Afify S, Berengy MS. Clinical characteristics and predictors of esophagogastric variceal bleeding among patients with HCV-induced liver cirrhosis: An observational comparative study. PLoS One 2022;17:e0275373. [PMID: 36227871 DOI: 10.1371/journal.pone.0275373] [Reference Citation Analysis]
2 Li J, Yu H, Wang Y, Wang B, Zhang R, Chen S, Duan G. A meta-analysis of the association between Helicobacter pylori infection and risk of hepatic encephalopathy. J Public Health (Oxf) 2022:fdac078. [PMID: 35924861 DOI: 10.1093/pubmed/fdac078] [Reference Citation Analysis]
3 Pan J, Wang L, Gao F, An Y, Yin Y, Guo X, Nery FG, Yoshida EM, Qi X. Epidemiology of portal vein thrombosis in liver cirrhosis: A systematic review and meta-analysis. European Journal of Internal Medicine 2022. [DOI: 10.1016/j.ejim.2022.05.032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Madala S, MacDougall K, Surapaneni BK, Park R, Girotra M, Kasi A. Coinfection of Helicobacter pylori and Hepatitis C Virus in the Development of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. J Clin Med Res 2021;13:530-40. [PMID: 35059071 DOI: 10.14740/jocmr4637] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Jun YK, Kim JW, Kim BG, Lee KL, Jung YJ, Kim W, Park HS, Lee DH, Koh S. Helicobacter pylori infection is not associated with portal hypertension-related gastrointestinal complications: A meta-analysis. PLoS ONE 2022;17:e0261448. [DOI: 10.1371/journal.pone.0261448] [Reference Citation Analysis]
6 Kugler TE, Taradin GG, Pellicano R. The role of <i>Helicobacter pylori</i> in metabolic and cardiovascular diseases. jour 2021. [DOI: 10.31146/1682-8658-ecg-193-9-86-95] [Reference Citation Analysis]
7 Abdel-Razik A, Shabana W, El Nakib AM, Abdelsalam M, Abdelwahab A, Hasan AS, Elzehery R, Elhelaly R, Fathy AA, Mostafa SA, El-Wakeel N, Moemen D, Eldars W, Yassen AH. De Novo Hepatocellular Carcinoma in Hepatitis C-Related Cirrhosis: Are Advanced Glycation End Products a Key Driver? Front Cell Infect Microbiol 2021;11:662431. [PMID: 34660332 DOI: 10.3389/fcimb.2021.662431] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Varon C, Azzi-Martin L, Khalid S, Seeneevassen L, Ménard A, Spuul P. Helicobacters and cancer, not only gastric cancer? Semin Cancer Biol 2021:S1044-579X(21)00219-4. [PMID: 34425210 DOI: 10.1016/j.semcancer.2021.08.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
9 Lankarani KB. Risk Factors for Portal Vein Thrombosis. Portal Vein Thrombosis 2021. [DOI: 10.1007/978-981-33-6538-4_3] [Reference Citation Analysis]
10 陈 思. Correlation between <i>Helicobacter pylori </i> and Complications of Liver Cirrhosis. ACM 2021;11:5327-5333. [DOI: 10.12677/acm.2021.1111787] [Reference Citation Analysis]
11 Alvarez CS, Florio AA, Butt J, Rivera-Andrade A, Kroker-Lobos MF, Waterboer T, Camargo MC, Freedman ND, Graubard BI, Lazo M, Guallar E, Groopman JD, Ramírez-Zea M, McGlynn KA. Associations between Helicobacter pylori with nonalcoholic fatty liver disease and other metabolic conditions in Guatemala. Helicobacter 2020;25:e12756. [PMID: 33006810 DOI: 10.1111/hel.12756] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
12 Abdel-Razik A, Mousa N, Zakaria S, Abdelsalam M, Eissa M, Abd El-Ghany MI, Hasan AS, Elhelaly R, Elzehery R, El-Wakeel N, Eldars W. Advanced Glycation End Products as a Predictor of Diabetes Mellitus in Chronic Hepatitis C-Related Cirrhosis. Front Med (Lausanne) 2020;7:588519. [PMID: 33195350 DOI: 10.3389/fmed.2020.588519] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
13 Pellicano R, Ianiro G, Fagoonee S, Settanni CR, Gasbarrini A. Review: Extragastric diseases and Helicobacter pylori. Helicobacter 2020;25 Suppl 1:e12741. [PMID: 32918343 DOI: 10.1111/hel.12741] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]